FLT1 and preeclampsia: Emerging datasuggests that pregnant patients with COVID-19 who develop this preeclampsia likesyndrome may be distinguished from traditional preeclampsia by soluble fms-liketyrosine kinase-1 (sFlt-1) [82], though this association requires further reviewand validation.